Stay updated on FG-3019 Safety in Idiopathic Pulmonary Fibrosis Clinical Trial
Sign up to get notified when there's something new on the FG-3019 Safety in Idiopathic Pulmonary Fibrosis Clinical Trial page.

Latest updates to the FG-3019 Safety in Idiopathic Pulmonary Fibrosis Clinical Trial page
- Check2 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedPulmonary fibrosis was added to the Keywords/MeSH terms to better reflect the studied condition and improve indexing.SummaryDifference0.1%

- Check31 days agoChange DetectedRevision updated to v3.4.2 and the earlier v3.4.1 funding/operational notice was removed. No study-related content, eligibility criteria, or results were changed.SummaryDifference0.5%

- Check38 days agoChange DetectedAdded a public notice about a lapse in government funding and updated the page revision to v3.4.1, replacing v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check45 days agoChange DetectedGlossary UI is now shown and new QC-related metadata labels were added (Last Update Submitted that Met QC Criteria, No FEAR Act Data) with Revision updated to v3.4.0. The older label Last Update Submitted that met QC Criteria, No FEAR Act data, and Revision: v3.3.4 were removed.SummaryDifference0.3%

- Check52 days agoChange DetectedDifference0.3%

Stay in the know with updates to FG-3019 Safety in Idiopathic Pulmonary Fibrosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the FG-3019 Safety in Idiopathic Pulmonary Fibrosis Clinical Trial page.